GFAP and central nervous system cancer: GFAP is characteristic of astrocyte- and neural stem cell-derived gliomas in CNS tumors and is used to identify malignancies of glial origin, such as astrocytomas and GBM (Jung et al., 2007; Tichy et al., 2016; van Bodegraven et al., 2019a).